Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 278.89 Million INR | 56.62% |
| 2022 | 178.06 Million INR | 71.22% |
| 2021 | 104 Million INR | 5.18% |
| 2020 | 98.88 Million INR | 2.78% |
| 2019 | 96.2 Million INR | 261.76% |
| 2018 | 26.59 Million INR | -58.71% |
| 2017 | 64.4 Million INR | 85.35% |
| 2016 | 34.74 Million INR | 0.0% |
| 2015 | - INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| 2012 | - INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 30 Million INR | 22.85% |
| 2024 Q1 | 24.42 Million INR | -44.77% |
| 2023 Q4 | 44.22 Million INR | -32.6% |
| 2023 Q2 | 76.22 Million INR | -17.4% |
| 2023 Q3 | 65.61 Million INR | -13.91% |
| 2023 FY | 278.35 Million INR | 56.32% |
| 2023 Q1 | 92.28 Million INR | 12.02% |
| 2022 Q4 | 82.38 Million INR | 40.58% |
| 2022 Q2 | 16.51 Million INR | -29.67% |
| 2022 FY | 178.06 Million INR | 71.22% |
| 2022 Q1 | 23.48 Million INR | -59.83% |
| 2022 Q3 | 58.6 Million INR | 254.89% |
| 2021 Q4 | 58.45 Million INR | 284.46% |
| 2021 Q1 | 2.26 Million INR | -92.21% |
| 2021 Q3 | 15.2 Million INR | -45.86% |
| 2021 FY | 104 Million INR | 5.18% |
| 2021 Q2 | 28.08 Million INR | 1140.92% |
| 2020 Q4 | 29.05 Million INR | -28.78% |
| 2020 FY | 98.88 Million INR | 2.78% |
| 2020 Q1 | 6.86 Million INR | -88.5% |
| 2020 Q2 | 22.16 Million INR | 222.66% |
| 2020 Q3 | 40.79 Million INR | 84.11% |
| 2019 Q4 | 59.69 Million INR | 91.14% |
| 2019 FY | 96.2 Million INR | 261.76% |
| 2019 Q3 | 31.23 Million INR | 33126.6% |
| 2019 Q2 | 94 Thousand INR | -98.19% |
| 2019 Q1 | 5.18 Million INR | -61.27% |
| 2018 Q3 | 660 Thousand INR | -70.24% |
| 2018 Q4 | 13.38 Million INR | 1927.95% |
| 2018 Q2 | 2.21 Million INR | -78.53% |
| 2018 FY | 26.59 Million INR | -58.71% |
| 2018 Q1 | 10.33 Million INR | -15.48% |
| 2017 FY | 64.4 Million INR | 85.35% |
| 2017 Q3 | 19.97 Million INR | 245.42% |
| 2017 Q4 | 12.22 Million INR | -38.81% |
| 2017 Q1 | 26.42 Million INR | 4.54% |
| 2017 Q2 | 5.78 Million INR | -78.11% |
| 2016 Q1 | - INR | 0.0% |
| 2016 Q3 | 4.81 Million INR | 3.13% |
| 2016 Q2 | 4.67 Million INR | 0.0% |
| 2016 Q4 | 25.27 Million INR | 424.9% |
| 2016 FY | 34.74 Million INR | 0.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q4 | - INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| 2015 Q1 | - INR | 0.0% |
| 2015 Q3 | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q1 | - INR | 0.0% |
| 2013 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | - INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -2558.764% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 73.408% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 30.317% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 24.661% |
| Sunil Healthcare Limited | 901.91 Million INR | 69.078% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -1417.202% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.504% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 37.481% |
| Patidar Buildcon Limited | 2.3 Million INR | -11983.709% |
| Roopa Industries Limited | 715.53 Million INR | 61.023% |
| Smruthi Organics Limited | 1.27 Billion INR | 78.151% |
| Trident Lifeline Limited | 446.28 Million INR | 37.508% |
| PANJON LTD. | 125.52 Million INR | -122.188% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -84.549% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 41.867% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 95.689% |
| Crestchem Limited | 212.56 Million INR | -31.205% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -4923.271% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 58.548% |
| Tyche Industries Limited | 696.83 Million INR | 59.977% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 91.989% |
| Trimurthi Limited | 42.23 Million INR | -560.287% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 62.601% |
| Norris Medicines Limited | 56.35 Million INR | -394.874% |
| Zenlabs Ethica Limited | 585.63 Million INR | 52.378% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 77.762% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 80.912% |
| Parmax Pharma Limited | 154.24 Million INR | -80.813% |
| Veerhealth Care Limited | 142.13 Million INR | -96.218% |
| Deccan Health Care Limited | 597.28 Million INR | 53.307% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 93.983% |
| Makers Laboratories Limited | 1.03 Billion INR | 73.122% |
| Lactose (India) Limited | 1.13 Billion INR | 75.512% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 29.648% |
| Zenith Healthcare Limited | 144.71 Million INR | -92.715% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 48.052% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 69.552% |
| Denis Chem Lab Limited | 1.67 Billion INR | 83.382% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 90.921% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 80.355% |
| Colinz Laboratories Limited | 70.29 Million INR | -296.74% |
| Godavari Drugs Limited | 1.56 Billion INR | 82.204% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -24845.617% |
| Zenotech Laboratories Limited | 368.08 Million INR | 24.232% |
| Panchsheel Organics Limited | 1.05 Billion INR | 73.494% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 77.847% |
| Phaarmasia Limited | 305.93 Million INR | 8.839% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 97.943% |
| Medi-Caps Limited | 265.63 Million INR | -4.991% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 23.118% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 83.577% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 84.002% |
| Mercury Laboratories Limited | 755.59 Million INR | 63.09% |
| Gennex Laboratories Limited | 867.14 Million INR | 67.838% |
| BDH Industries Limited | 858.31 Million INR | 67.507% |
| Coral Laboratories Limited | 836.6 Million INR | 66.664% |
| Concord Drugs Limited | 449.24 Million INR | 37.92% |
| Bharat Parenterals Limited | 2.59 Billion INR | 89.249% |
| Beryl Drugs Limited | 271.24 Million INR | -2.818% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -171.09% |
| Evoq Remedies Limited | 63.09 Million INR | -342.054% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 86.199% |
| Transchem Limited | 4.09 Million INR | -6702.246% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -83.631% |
| Parnax Lab Limited | 1.88 Billion INR | 85.221% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -2.17% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 72.747% |
| Cian Healthcare Limited | 616.95 Million INR | 54.795% |
| Trinity League India Limited | 2.95 Million INR | -9353.966% |
| Syschem (India) Limited | 2.33 Billion INR | 88.058% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 82.056% |
| Auro Laboratories Limited | 526.99 Million INR | 47.079% |